{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:32:08Z","timestamp":1790843528765,"version":"4.1.0"},"reference-count":32,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7,1]]},"DOI":"10.1210\/jc.2009-2546","type":"journal-article","created":{"date-parts":[[2010,4,28]],"date-time":"2010-04-28T22:33:47Z","timestamp":1272494027000},"page":"3260-3267","source":"Crossref","is-referenced-by-count":149,"title":["Dissimilar Hepatotoxicity Profiles of Propylthiouracil and Methimazole in Children"],"prefix":"10.1210","volume":"95","author":[{"given":"Scott A.","family":"Rivkees","sequence":"first","affiliation":[{"name":"Yale Pediatric Thyroid Center (S.A.R.), Yale University School of Medicine, New Haven, Connecticut 06520"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Szarfman","sequence":"additional","affiliation":[{"name":"Center for Drug Evaluation and Research (A.S.), U.S. Food and Drug Administration, Silver Spring, Maryland 20993"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113385845000_R1","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1515\/JPEM.2006.19.9.1095","article-title":"The treatment of Graves\u2019 disease in children.","volume":"19","author":"Rivkees","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113385845000_R2","unstructured":"Eunice Kennedy Shriver National Institute of Child Health and Human Development 2009 Hepatic toxicity following treatment for pediatric graves\u2019 disease meeting: October 28, 2008. http:\/\/bpca.nichd.nih.gov\/outreach\/index.cfm"},{"key":"key\n\t\t\t\t2019041113385845000_R3","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1210\/jc.2009-0850","article-title":"Putting propylthiouracil in perspective.","volume":"94","author":"Cooper","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113385845000_R4","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1056\/NEJMc0809750","article-title":"Ending propylthiouracil-induced liver failure in children.","volume":"360","author":"Rivkees","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113385845000_R5","doi-asserted-by":"crossref","first-page":"132041","DOI":"10.1186\/1687-9856-2009-132041","article-title":"Propylthiouracil (PTU) hepatoxicity in children and recommendations for discontinuation of use","volume":"2009","author":"Rivkees","year":"2009","journal-title":"Int J Pediatr Endocrinol"},{"key":"key\n\t\t\t\t2019041113385845000_R6","first-page":"67","article-title":"Empirical Bayes screening for multi-item associations","author":"DuMouchel","year":"2001","journal-title":"Proc Conference on Knowledge Discovery and Data, San Diego, CA, 2001, pp"},{"key":"key\n\t\t\t\t2019041113385845000_R7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00002018-200225060-00001","article-title":"Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA\u2019s spontaneous reports database.","volume":"25","author":"Szarfman","year":"2002","journal-title":"Drug Saf"},{"key":"key\n\t\t\t\t2019041113385845000_R8","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/rheumatology\/ken321","article-title":"Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis.","volume":"47","author":"Gao","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t2019041113385845000_R9","doi-asserted-by":"crossref","first-page":"R1072","DOI":"10.1186\/ar1789","article-title":"Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides","volume":"7","author":"Bonaci-Nikolic","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"key\n\t\t\t\t2019041113385845000_R10","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/thy.2000.10.595","article-title":"Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves\u2019 disease.","volume":"10","author":"Sera","year":"2000","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113385845000_R11","first-page":"282","article-title":"Propylthiouracil-induced cutaneous vasculitis.","volume":"35","author":"Yarman","year":"1997","journal-title":"Int J Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t2019041113385845000_R12","first-page":"274","article-title":"Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves\u2019 disease treated with propylthiouracil or methimazole in Taiwan.","volume":"103","author":"Huang","year":"2004","journal-title":"J Formos Med Assoc"},{"key":"key\n\t\t\t\t2019041113385845000_R13","first-page":"1719","article-title":"Predictors of early remission of hyperthyroidism in children.","volume":"82","author":"Glaser","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113385845000_R14","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.1542\/peds.2007-1535","article-title":"Predicting the likelihood of remission in children with Graves\u2019 disease: a prospective, multicenter study","volume":"121","author":"Glaser","year":"2008","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t2019041113385845000_R15","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1210\/jcem-60-5-1019","article-title":"Management of hyperthyroidism in children and adolescents.","volume":"60","author":"Hamburger","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113385845000_R16","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1210\/jcem-64-6-1241","article-title":"Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years.","volume":"64","author":"Lippe","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113385845000_R17","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1210\/jc.2008-0842","article-title":"Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment.","volume":"93","author":"Kaguelidou","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113385845000_R18","first-page":"1083","article-title":"Severe cholestatic jaundice in uncomplicated hyperthyroidism treated with methimazole.","volume":"80","author":"Arab","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113385845000_R19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1159\/000201271","article-title":"Cholestasis induced hyperthyroidism after liver transplantation.","volume":"56","author":"Lersch","year":"1995","journal-title":"Digestion"},{"key":"key\n\t\t\t\t2019041113385845000_R20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00571690","article-title":"Methimazole-induced cholestatic liver injury, mimicking sclerosing cholangitis.","volume":"381","author":"Schwab","year":"1996","journal-title":"Langenbecks Arch Chir"},{"key":"key\n\t\t\t\t2019041113385845000_R21","first-page":"200","article-title":"Delayed cholestatic hepatitis due to methimazole.","volume":"5","author":"Hung","year":"1999","journal-title":"Hong Kong Med J"},{"key":"key\n\t\t\t\t2019041113385845000_R22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/01.SMJ.0000054690.98272.B1","article-title":"Methimazole-induced cholestatic jaundice.","volume":"97","author":"Mikhail","year":"2004","journal-title":"South Med J"},{"key":"key\n\t\t\t\t2019041113385845000_R23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.amjopharm.2007.10.003","article-title":"Methimazole-induced cholestatic jaundice in an elderly hyperthyroid patient.","volume":"5","author":"Ramos-Bonner","year":"2007","journal-title":"Am J Geriatr Pharmacother"},{"key":"key\n\t\t\t\t2019041113385845000_R24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2169\/internalmedicine.31.377","article-title":"Lactate dehydrogenase (LDH)-linked immunoglobulin in a patient with Graves\u2019 disease treated with methimazole.","volume":"31","author":"Gemma","year":"1992","journal-title":"Intern Med"},{"key":"key\n\t\t\t\t2019041113385845000_R25","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4158\/EP.8.3.222","article-title":"Methimazole-induced hepatotoxicity.","volume":"8","author":"Woeber","year":"2002","journal-title":"Endocr Pract"},{"key":"key\n\t\t\t\t2019041113385845000_R26","first-page":"244","article-title":"Methimazole-associated cholestatic liver injury: case report and brief literature review.","volume":"33","author":"Schmidt","year":"1986","journal-title":"Hepatogastroenterology"},{"key":"key\n\t\t\t\t2019041113385845000_R27","first-page":"693","article-title":"[Acquired sideroblastic anemia and cholestasis in a hyperthyroid patient treated with methimazole and atenolol]","volume":"55","author":"Mamianetti","year":"1995","journal-title":"Medicina (B Aires)"},{"key":"key\n\t\t\t\t2019041113385845000_R28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3904\/kjim.1990.5.1.69","article-title":"A case of methimazole-induced acute hepatic failure in a patient with chronic hepatitis B carrier.","volume":"5","author":"Kang","year":"1990","journal-title":"Korean J Intern Med"},{"key":"key\n\t\t\t\t2019041113385845000_R29","first-page":"17","article-title":"Unusual complications of antithyroid drug therapy: four case reports and review of literature.","volume":"1","author":"Baker","year":"1989","journal-title":"Thyroidology"},{"key":"key\n\t\t\t\t2019041113385845000_R30","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/lt.20204","article-title":"Liver transplantation for acute liver failure from drug induced liver injury in the United States.","volume":"10","author":"Russo","year":"2004","journal-title":"Liver Transpl"},{"key":"key\n\t\t\t\t2019041113385845000_R31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/00002018-200326050-00001","article-title":"Application of quantitative signal detection in the Dutch spontaneous reporting system for adverse drug reactions.","volume":"26","author":"Puijenbroek","year":"2003","journal-title":"Drug Saf"},{"key":"key\n\t\t\t\t2019041113385845000_R32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/thy.2009.0169","article-title":"The role of propylthiouracil in the management of Graves\u2019 disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration.","volume":"19","author":"Bahn","year":"2009","journal-title":"Thyroid"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/95\/7\/3260\/9067573\/jcem3260.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:38:02Z","timestamp":1559061482000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/95\/7\/3260\/2596315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,1]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2009-2546","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,1]]}}}